Semaglutide stimulates GLP-1 receptors to increase insulin secretion in response to meals, suppress glucagon, and slow gastric emptying, while tirzepatide adds GIP receptor action that further reduces appetite and body weight
For larger botanical molecules, specialized carrier systems are needed to get through the skin barrier effectively
Pal-Isleucine is also in there, which combines fats and amino acids, to help skin stay firmer and more elastic
Klausen MK, Jensen ME, Mller M, Le Dous N, Jensen A, Zeeman VA, Johannsen CF, Lee A, Thomsen GK, Macoveanu J, Fisher PM, Gillum MP, Jrgensen NR, Bergmann ML, Enghusen Poulsen H, Becker U, Holst JJ, Benveniste H, Volkow ND, Vollstdt-Klein S, Miskowiak KW, Ekstrm CT, Knudsen GM, Vilsbll T, Fink-Jensen A
Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al
Regarding the specific concern about blood clots (venous thromboembolism) , there is no established causal link between GLP-1 receptor agonists and increased thrombotic risk
